CKM Research
Cancun, Mexico · Mexico
Research profile compiled by Stem Cell Navigator from public sources. Every fact carries a source and a verification status.
Research-backed provider profile. Each recorded fact is labelled Clinic says , Verified , Pending verification or Not disclosed , with the source we checked. Inclusion is not an endorsement and nothing here indicates that a treatment is safe or effective.
Overview
This is a research profile, not a provider listing. Stem Cell Navigator recorded what this provider publishes about itself, checked what could be checked against independent sources, and left everything else visibly unverified or not disclosed. Inclusion is not an endorsement.
Recorded facts and sources
Every field is asked of every provider in the same way. Where a provider has not published something, that absence is recorded rather than filled in.
1. Identity, location and access
Who the provider is and how an international patient reaches them.
- Legal entity name
No registered legal operating entity is named on the reviewed public pages.
Not disclosed- Trading / brand name
CKM Research, marketed at ckmresearch.com. The provider also has material published under the CKM Stem Cells brand at ckmstemcells.com.
Clinic says- Country
Mexico
Clinic says- City
Cancun, Quintana Roo
Clinic says- Treatment address
Calle Ciricote 499, 77533 Cancun, Q.R., Mexico, as shown on the current website. Earlier provider material and a Waze place listing show Calle Ciricote 399, L101. The difference is unresolved.
Conflicting information- Official website
https://www.ckmresearch.com/
Clinic says- Published contact details
US phone 612-314-6007 and email info@ckmresearch.com are shown on the current site. The same page also visibly displays a placeholder address, (info@mysite.com), next to the contact email. Recorded as a website contact-data inconsistency only.
Clinic says- International patient support
The provider states that it supports international patients and helps arrange travel.
Clinic says
2. Facility, regulatory and licensing
Licensing and regulatory position as claimed and as independently checked.
- Facility type
Describes itself as a stem cell therapy clinic and research centre. No hospital affiliation is stated.
Clinic says- Regulating authority
COFEPRIS, the Mexican federal health regulator.
Verified- Licence reference
No sanitary-licence number, licensed legal entity, SEASS_REGEN entry, responsible sanitary professional or licence scope for the current premises was identified in public sources during this review.
Pending verification- Accreditations
The provider describes itself as COFEPRIS-Certified and says it complies with COFEPRIS guidelines and international standards. Provider claims COFEPRIS certification and compliance; exact licence documentation is pending independent verification.
Pending verification- Regulatory pathway for biologics
Official COFEPRIS material defines specific sanitary-licence categories for regenerative medicine (COFEPRIS-09-027) and for stem-cell collection and banking (09-026 A and B), and COFEPRIS maintains a SEASS_REGEN list of establishments using stem cells or regenerative medicine.
Verified
3. Physician leadership and credentials
Named clinicians responsible for care, and whether credentials were checked.
- Medical director
Dr. Omar Josue Rojas Vazquez. The full name is corroborated by two independent public physician directories.
Verified- Director credentials
CKM presents him as Doctor and Stem Cell Specialist. That title is the provider marketing description and is recorded separately from the credential shown in public registers.
Clinic says- Licence verification
The cedula number appears in two independent public directories. The scope of practice for the procedures marketed, and any additional licensing, were not verified in this review.
Verified- Credential as listed in public directories
Public physician directories classify the credential as Medico General (general practitioner). No independently sourced board specialty in regenerative medicine was identified in this review.
Verified- Professional licence / cédula number
Professional cedula 12409484, as published in public physician directories.
Verified- Other treating clinicians
The about page names Jessie as Clinic Manager and Jon as Consultant. No surnames, licences, clinical roles or ownership details are disclosed for either.
Clinic says
4. Modalities offered
What the clinic offers, kept separate from any evidence context.
- Stem cell therapies offered
The FAQ describes mesenchymal stem cell (MSC) therapies and NK-cell therapy.
Clinic says- Exosomes / EVs offered
The provider markets exosome therapy and exosome protocols.
Clinic says- Peptides offered
No peptide offering is described on the reviewed pages.
Pending verification- PRP / orthobiologics offered
No PRP offering is described. An ultrasound-guided intra-articular procedure is referenced under orthopedic care.
Pending verification- Other modalities
The FAQ also references placental protein extract, growth-factor and anti-aging offerings, and a hyperbaric chamber.
Clinic says
5. Biologic and source details
Where the biologic comes from and how it is made and tested.
- Autologous or allogeneic
Not stated on the reviewed pages.
Not disclosed- Tissue source
No tissue source for the cells used is stated on the reviewed pages.
Not disclosed- Donor screening
No donor screening or infectious-disease testing protocol is described.
Not disclosed- Processing method
No processing or culture method is described.
Not disclosed- Culture expansion
Not stated on the reviewed pages.
Not disclosed- Lab or manufacturer
No laboratory or third-party manufacturer is named.
Not disclosed- Quality and release testing
No release testing or quality control process is described.
Not disclosed- Cell count per administration
No dose in cells per administration is published.
Not disclosed- Viability
No viability figure is published.
Not disclosed
6. Protocol and delivery
How treatment is actually administered.
- Routes of administration
No administration routes are stated other than a reference to ultrasound-guided intra-articular injection for joint procedures.
Not disclosed- Number of administrations
Not stated on the reviewed pages.
Not disclosed- Imaging guidance
The FAQ describes ultrasound-guided intra-articular procedures taking roughly 30 to 45 minutes under local anaesthetic with minimal recovery.
Clinic says- Length of stay
Not stated on the reviewed pages.
Not disclosed- Adjunct therapies
References hyperbaric chamber therapy used alongside stem cell treatment.
Clinic says
7. Conditions the clinic says it treats
Clinic-stated scope only. This section never implies evidence or efficacy.
- Stated conditions treated
The provider markets autoimmune conditions, orthopedic and sports injury, neurological conditions and exosome protocols. Its neurological page names stroke, spinal-cord injury, multiple sclerosis, peripheral neuropathy, cerebral palsy, autism and TBI/CTE.
Clinic says- Stated exclusions
No excluded conditions are stated on the reviewed pages.
Not disclosed- Candidacy screening
The provider states that it supports patients from first contact through the months after treatment and coordinates travel. No clinical eligibility or screening criteria are published.
Clinic says
8. Evidence context
Sourced evidence context. Kept structurally separate from the Evidence Grade.
- Publications cited by the clinic
The provider cites general third-party peer-reviewed literature on its neurological and autism pages. Those papers are external literature about the field; none of them studied this provider's own product, batch, protocol, dose or patient outcomes.
Clinic says- Registered trials
No trial registry entry tied to this provider was located, despite the "Research" element of the trading name.
Pending verification- Clinic-reported outcomes
References patient success stories. No outcome dataset, measurement method or aggregate result has been published.
Clinic says- Independent context note
No clinical publication, registered trial, abstract or outcome dataset specific to this provider was identified in this research pass.
Pending verification
9. Safety, monitoring and follow-up
Process and capability, not a safety assessment.
- Stated contraindications
No contraindications are described on the reviewed pages.
Not disclosed- Adverse-event process
No adverse-event recording or reporting process is described.
Not disclosed- Follow-up programme
The provider states that its support continues for months after treatment. The follow-up schedule, who conducts it and what is measured are not published.
Clinic says
10. Economics
Pricing as disclosed. Absence of a published price is itself recorded.
- Starting price (USD)
Not publicly disclosed in the sources reviewed.
Not disclosed- Package structure
References wellness packages and comprehensive plans without describing what they contain.
Clinic says- Inclusions
Not itemised on the reviewed pages.
Not disclosed
11. Travel and logistics
What a travelling patient needs to plan.
- Ground transport
States that travel arrangements are facilitated so the patient can focus on treatment and recovery. Specific transport provision is not described.
Clinic says- Lodging support
No lodging arrangement is described.
Not disclosed- Recommended stay
Not stated on the reviewed pages.
Not disclosed
12. Navigator layer
Transparency Score, Evidence Grade and verification completeness are three separate concepts and are never combined.
- Review scope
This pass reviewed the provider's current public pages, an older provider site, two independent physician directories, a public place listing and official COFEPRIS framework pages. It did not include provider-supplied documents, licence records, laboratory records or any site visit.
Pending verification- Open questions and published inconsistencies
Three unresolved items. First, the current site gives Calle Ciricote 499 while earlier provider material and a Waze place listing give Calle Ciricote 399, L101; whether this is a move, a renumbering, a typo or a separate location is unresolved and Navigator has not resolved it independently. Second, the autism page uses the term Signature Cells without defining what the product is. Third, no clinical publication or registered trial specific to this provider was identified.
Conflicting information
13. Historical provider statements and brand continuity
Statements published earlier by the same provider or an earlier brand. Historical text is never treated as a current fact; each row needs current confirmation.
- Earlier or parallel brand
An older or parallel provider site, ckmstemcells.com, publishes CKM Stem Cells material. The relationship between the CKM Stem Cells and CKM Research brands is not explained on either site.
Clinic says (public source)- Historical addresses
Earlier material shows Avenida Huayacan esq. Calle Ciricote 399, L101, Ossis Wellness Plaza, primer piso, SM 313, Cancun, Q. Roo, and a second location, CRT Chapala — Ajijic 153, Hospital RMC, San Antonio Tlayacapan, Jalisco.
Clinic says (public source)- Historical contact details
Earlier material shows US phone +1 (651) 391-7042 and email info@ckmstemcells.com.
Clinic says (public source)- Historical stated tissue source
Earlier material stated that MSCs were sourced from placental tissue and Wharton's Jelly and were expanded and processed under regulatory standards. The current site does not state a tissue source.
Clinic says (public source)- Historical service menu
The earlier menu included aesthetics and anti-aging, exosomes, MSCs and NK cells. Related site content also references placental protein extract, fibroblast rejuvenation and MSC growth factors for alopecia.
Clinic says (public source)- Historical disclaimers
The earlier FAQ stated that stem cell therapy offers no guarantees and is not promoted as a cure.
Clinic says (public source)
14. Data gaps — what we still need from this provider
Open requests, not findings. An item here means the information was not located in public sources during this review; it does not imply anything is wrong.
- Legal entity and ownership
Legal entity name, ownership, RFC tax registration and incorporation date.
Pending verification- Exact current address
Exact current facility address and suite, and an explanation of the 399 versus 499 difference: move, renumbering, typo or separate location.
Pending verification- Sanitary licence documentation
Exact COFEPRIS sanitary-licence number or numbers, licence category and scope, SEASS_REGEN entry, issue date, licence holder and legal entity, and the responsible sanitary professional, together with confirmation that the scope covers the current premises and procedures.
Pending verification- Processing model
Whether the clinic processes cells itself, uses an external cell bank or laboratory, or both.
Pending verification- Cell manufacturer or bank
Name and legal entity of the cell manufacturer, bank or laboratory, and its applicable licences.
Pending verification- Current tissue source and donor screening
Current MSC tissue source, including whether placental tissue and Wharton's Jelly remain current, plus donor eligibility and screening procedures.
Pending verification- Process and product specification
Cell isolation and expansion process, passage number, cryopreservation status, cell count or dose per treatment, and viability at release and at administration.
Pending verification- Batch release testing and certificate of analysis
Sterility, endotoxin, mycoplasma and any other batch-release testing, and whether a patient can receive the certificate of analysis for their own batch.
Pending verification- Exosome product details
Exosome source, manufacturing process, characterisation, particle count and dose, sterility and other testing, and the regulatory basis for use.
Pending verification- Meaning of proprietary product names
Exactly what Signature Cells means at this clinic: manufacturer and source, formulation, cell count, route, viability and release criteria, and whether the term is proprietary, licensed or generic.
Pending verification- Protocol by indication
Protocol by indication: routes, doses, number and timing of treatments, and any adjunct therapies.
Pending verification- Pricing and package inclusions
Public pricing and package inclusions and exclusions. No price was found in the public sources reviewed.
Pending verification- Treating clinicians
Treating physicians beyond the named medical director, with their roles and credentials.
Pending verification- Adverse-event and escalation process
How adverse events are captured and reported, and the emergency escalation arrangement.
Pending verification- Follow-up and outcome measurement
The longitudinal follow-up process and which outcomes are systematically measured.
Pending verification- Documented treatment volume
Total patient volume and treatment count by indication, if the provider is willing to document it.
Pending verification- Provider-specific evidence
Any registered clinical trials, publications, abstracts or outcome datasets specific to this provider.
Pending verification- Status of other locations
Whether the historical Ajijic and Chapala location is still active, and how it relates to the current entity.
Pending verification- Relationship between brands
The relationship between the CKM Stem Cells and CKM Research brands and websites.
Pending verification- Privacy and data-handling policy
Privacy and data-handling policy and terms applying to international patient enquiries.
Pending verification
Navigator scoring status
This profile records what a provider publishes about itself and what independent sources confirm. Stem Cell Navigator does not provide medical advice, diagnosis or treatment, does not endorse any provider, and a recorded claim is not evidence that a treatment works.